In Brief: Pfizer
This article was originally published in The Gray Sheet
Executive Summary
Pfizer: Enters agreement to acquire Mountain View, California-based Vesta Medical, developer of the VestaBlate uterine balloon system for the treatment of excessive uterine bleeding. U.S. clinical trials for the device began in January ("The Gray Sheet" Feb. 12, I&W-4). Upon completion of the acquisition, expected within a month, VestaBlate will be manufactured and marketed by Pfizer's Valleylab subsidiary. Terms of the deal were not disclosed...